Business Context and Reporting Period
This Form 8-K reports on the 2018 Annual Meeting of Stockholders held by NanoViricides, Inc. on November 30, 2018. The filing details the voting results for director elections, executive compensation plans, and the ratification of the independent auditor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes rather than financial performance.
Material Changes and Voting Results
Approximately 77% of the Company's outstanding voting capital stock was present at the meeting. Key outcomes included:
- Director Elections: Stanley Glick (Class III) and James Sapirstein (Class I) were elected. Irach Taraporewala (Class II) was not elected.
- Compensation Plans: Stockholders approved the 2018 Executive Equity Incentive Plan.
- Executive Awards: Stockholders approved a grant of warrants for 250,000 shares to the Former CEO (severance) and an award of 525,000 Series A Convertible Preferred Stock to the President (employment extension).
- Auditor Ratification: Eisner Amper, LLP was ratified as the independent registered public accounting firm for the fiscal year ending June 30, 2019.
Voting Breakdown
| Proposal | Votes For | Votes Against/Withheld | Abstained | Broker Non-Votes |
|---|---|---|---|---|
| Re-election of Stanley Glick | 51,137,324 | 19,535,430 | - | 21,056,181 |
| Election of James Sapirstein | 69,218,461 | 1,184,293 | - | 21,056,181 |
| Election of Irach Taraporewala | 31,734,893 | 45,082,189 | - | 21,056,181 |
| Executive Equity Incentive Plan | 56,679,912 | 19,505,506 | 305,543 | 21,056,181 |
| Warrants to Former CEO | 47,235,164 | 21,865,459 | 1,304,631 | 21,056,181 |
| Preferred Stock to President | 48,638,004 | 21,037,127 | 730,123 | 21,056,181 |
| Ratify Auditor (Eisner Amper) | 81,648,954 | 16,009,480 | 567,759 | 21,056,181 |
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, outlook, management commentary on financial risks, or contingencies. The document references a Proxy Statement filed on October 19, 2019 (likely a typo in the source text for 2018) for further details on proposals.
Investor Verification Checklist
- Verify the impact of the failed election of Irach Taraporewala on board composition and strategy.
- Review the terms of the 250,000 warrants granted to the Former CEO and the 525,000 Series A Preferred Shares granted to the President.
- Confirm the fiscal year end date (June 30) and the appointment of Eisner Amper, LLP as the auditor.
- Check the referenced Proxy Statement for detailed descriptions of the Executive Equity Incentive Plan.